Cargando…
Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease
Cardiovascular disease (CVD) is the leading cause of death in patients with non-alcoholic fatty liver disease (NAFLD). Curcumin has been shown to exert glucose-lowering and anti-atherosclerotic effects in type 2 diabetes. Hence, we investigated curcumin’s effects on atherogenesis markers, fatty live...
Autores principales: | Naseri, Kaveh, Saadati, Saeede, Yari, Zahra, Askari, Behzad, Mafi, Davood, Hoseinian, Pooria, Asbaghi, Omid, Hekmatdoost, Azita, de Courten, Barbora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370510/ https://www.ncbi.nlm.nih.gov/pubmed/35956400 http://dx.doi.org/10.3390/nu14153224 |
Ejemplares similares
-
The effects of probiotic and synbiotic supplementation on inflammation, oxidative stress, and circulating adiponectin and leptin concentration in subjects with prediabetes and type 2 diabetes mellitus: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials
por: Naseri, Kaveh, et al.
Publicado: (2022) -
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
por: Saadati, Saeede, et al.
Publicado: (2019) -
Nigella sativa supplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
por: Saadati, Saeede, et al.
Publicado: (2022) -
Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease
por: Saadati, Saeede, et al.
Publicado: (2018) -
Salt consumption and mortality risk in cirrhotic patients: results from a cohort study
por: Pashayee-Khamene, Fereshteh, et al.
Publicado: (2022)